Bolt Biotherapeutics (NASDAQ:BOLT) Given “Neutral” Rating at HC Wainwright
Bolt Biotherapeutics (NASDAQ:BOLT – Get Free Report)‘s stock had its “neutral” rating restated by equities researchers at HC Wainwright in a report released on Tuesday,Benzinga reports. Separately, Stifel Nicolaus lowered their price target on Bolt Biotherapeutics from $1.50 to $1.25 and set a “hold” rating on the stock in a research report on Tuesday. Five […]
Bolt Biotherapeutics (NASDAQ:BOLT – Get Free Report)‘s stock had its “neutral” rating restated by equities researchers at HC Wainwright in a report released on Tuesday,Benzinga reports. Separately, Stifel Nicolaus lowered their price target on Bolt Biotherapeutics from $1.50 to $1.25 and set a “hold” rating on the stock in a research report on Tuesday. Five […]
